Advertisement

Topics

Shanghai GT Apeiron Launches; Partners with AI Drug Discovery Company Exscientia

05:33 EDT 12 Jun 2019 | ChinaBio Today

GT Apeiron Therapeutics, a Shanghai novel biotech, was launched with backing from GT Healthcare Capital Partners and associated investors. GT Healthcare is a Hong Kong-based private investment partnership specialized in healthcare investments, especially in Asia. Apeiron also announced a drug discovery collaboration with Exscientia, a UK AI drug discovery company. Exscientia aims to combine AI with the discovery experience of veteran drug hunters. Using Exscientia's AI platform, Apeiron expects to accelerate its novel drug development, exploring new pathways for important oncology therapeutic targets. More details....

Share this with colleagues:

Original Article: Shanghai GT Apeiron Launches; Partners with AI Drug Discovery Company Exscientia

NEXT ARTICLE

More From BioPortfolio on "Shanghai GT Apeiron Launches; Partners with AI Drug Discovery Company Exscientia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...